Previous id grand Rounds



Download 277.87 Kb.
Date31.01.2017
Size277.87 Kb.

Previous ID Grand Rounds

2010


1/27/10

William Klingensmith, MD

Imaging Infection with FDG & PET-CT: The Best Imaging Study for Infection

Professor of Radiology, Director, Division of Nuclear Medicine, UC Denver

2/10/10

Robert Belknap, MD

INFgamma Release Assays for Diagnosis of TB

Assistant Professor, Division of Infectious Diseases - UC Denver

2/17/10

Alia Al-Tayyib, PhD

HIV Behavioral Surveillance Project

Assistant Research Scientist, Assistant Professor Epidemiology Department, Colorado School of Public Health

3/3/10

Kevin High, MD

HIV and Aging: Pathogenesis, Outcomes and Future Research Priorities

Professor of Medicine, Chief, Section of Infectious Diseases, Wake Forest University

3/10/10

Richard Haubrach, MD

Regimens for Treatment Experienced HIV-Infected Patients: Which Agents, How Many and Why (and How the Resistance Test Can Help)

Professor of Medicine, Division of Infectious Diseases, University of California, San Diego, CA

3/31/10

Carlos Del Rio, MD

Tim Gill Lecture Presentation: Sex, Drugs, and HIV: The Synergistic Epidemics of Crack Cocaine and HIV

Professor/Chair - Hubert Department of Global Health, Rollins School of Public Health. Professor of Medicine in Infectious Diseases at the Emory University School of Medicine

4/7/10

Ken Tyler, MD

West Nile Virus Neuroinvasive Disease

Reuler-Lewin Family Professor and Chair of Neurology. Professor of Medicine, Microbiology and Immunology UC Denver

5/5/10

Marinka Kartalija, MD

Characterizing Body Morphotype and Serum Adipokine & Cytokine Levels in Patients with Nontuberculosis Mycobacteruak (NTM) Lung Disease

Fellow, Infectious Diseases, UC Denver

5/12/10

Jing Kroll, MD

The use of EBV Lytic and Latency III mRNA and of Viral DNA for Early Detention of PTLD

Fellow, Infectious Diseases, UC Denver

6/2/10

Kristine Erlandson, MD




Fellow, Infectious Diseases, UC Denver

6/16/10

Margaret McLees, MD




Fellow, Infectious Diseases, UC Denver

2009


2/4/2009

Sam MaWhinney, PhD

Statistics 101

Professor, Preventive Medicine and Biostatistics – UC Denver

4/1/2009

Alicia Cronquist, RN, MPH

Trends in Shiga toxin-producing E. Coli (STEC) Infection

Foodborne/Enteric Disease Epidemiologist. CO Dept. of Public Health and Environment

5/6/2009

Beth Jamieson, PhD

The Dual Impact of HIV and Age on T-Cells; Why getting HIV makes you old

Associate Professor, Division of Hematology & Oncology, UCLA David Geffen School of Medicine

6/3/2009

Vivian Cox, MD

HIV-1 Infection of Follicular CD4+ Lymphocites

ID Fellow – UC Denver

8/12/2009

Mary Kestler, MD

TB/HIV Education and Care Program for Health Care Workers in Botswana

Head, TB/HIV Program, Botswana-University of Pennsylvania

8/19/2009

Joshua Christensen, MD

Metabolic Drug Targets in TB

ID Fellow, UC Denver

9/9/2009

Nina Singh, MD

Current Challenges and Evolving Concepts in the Management of Invasive Fungal Infections in Solid Organ Transplant Recipients

Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh

9/16/2009

Eric Kajioka, MD

Risk Factors of Clostridium Difficile Infection in Hospitalized Adults

ID Fellow, UC Denver

9/30/2009

Charles Steinberg, MD

AIDS in Africa, One Colorado Doctor’s Experience

Consultant and Trainer, ID Institute

11/11/2009

Dan Bausch, MD

Challenges to Diagnosis the Viral Hemorrhagic Fevers

Associate Professor, Department of Tropical Medicine, Tulane School of Public Health and Tropical Medicine

2008


Date

Speaker 

Topic

Affiliation/Contact

1/10/2008

Theresa Pacheco, MD

HIV Lipoatrophy

Medical Director, Associate Professor, Department of Dermatology, UC Denver

1/17/2008

Ralph Wilmoth

The Current Increase in Syphillis

STD/HIV Section Chief, CDPHE

1/24/2008

Dennis Stevens, MD, PhD

Pathogenic Mechanisms and Antimicrobial Treatment of Toxin Related Infections Caused by Gram Positive Microbes

Professor of Medicine, University of Washington

1/31/2008

David Margolis, MD

Mechanisms that Maintain HIV Latency: Targets for Future Therapeutics to Eradicate Persistent Infection

Professor of Medicine, Microbiology and Immunology, Epidemiology, University Of North Carolina at Chapel Hill

2/14/2008

William Claude Klingensmith, MD

Imaging Infection with FDG & PET-CT

Director, Hewit Biomolecular Imaging Center, Porter Hospital

2/21/2008

Dan Kuritzes, MD

HIV-1 Entry, Chemokine Receptors, and CCR5 Antagonists

Professor of Medicine, Harvard Medical School

3/6/2008

Glenn Treisman, MD, PhD

HIV and Depression

Director of HIV Mental Health, Johns Hopkins

3/13/2008

Thomas Gootz, MD

Carbapenem-Resistance in Klebisiella Pneumoniae, a Global Problem

Department of Antibiotics, Immunology, and Cancer, Pfizer

3/20/2008

Hugo Rosen, MD

Hepatitis C

Professor of Medicine, Division Head of Gastroenterology, UC Denver

4/10/2008

Edward Gardner, MD

HIV and Medication Adherence

Assistant Professor of ID, UC Denver

4/17/2008

Rohini Sharma, MD

Staphylococcus and Epidural Abscesses

ID Fellow, UC Denver

5/1/2008

Rawleigh Howe, MD

Dendritic Cells and HIV

ID Fellow, UC Denver

5/15/2008

Minal Kapoor, MD

Central Blood Stream Infection Prevention

ID Fellow, UC Denver

5/22/2008

Daniel Musher, MD

Syphillis

Professor of Medicine, Baylor University

6/5/2008

Timothy Jenkins, MD

CA-MRSA USA300 Bloodstream Infections in Denver’s Health Care System

ID Fellow, UC Denver

6/12/2008

Carla Saveli, MD

The Role of Antibiotics in Open Fractures in the Era of CA-MRSA

ID Fellow, UC Denver

6/18/2008

Mary Kestler, MD

Delays in the Diagnosis of Tuberculosis

ID Fellow, UC Denver

9/3/2008

Michelle Haas, MD

HIV-1 Infection of FollicularCD4+ cells may be associated with increased BCl-2 levels and affect cell survival: Implications for persistent viral replication in lymphoid tissues

ID Fellow, University of Colorado Denver

10/1/2008

David Cohn, MD

TB Infection Control in Resource Limited Settings; Can it Be Done? 

Professor of Medicine, Denver Health Hospital

10/15/2008

Douglas Fish, PharmD

Antimicrobial Pharmacodynamics: Assessing the role of Monte Carlo Simulation

Professor, School of Pharmacy

10/29/2008

Jerry Nick, MD

Neutrophil-induced enhancement of Pseudomonas aeruginosa biofilms

Assistant Professor, Division of Pulmonary Medicine, National Jewish Center

12/3/2008

Donald Gilden, MD




Professor, Department of Microbiology, UC Denver

2007


Date

Speaker 

Topic

Affiliation/Contact

1/11/2007

Elizabeth Connick, M.D.

Primary HIV-1 Infection

UCD

1/18/2007

Edward Chan, M.D.

The skinny on Mycobacterium abscessus infection

UCD

2/1/2007

Thomas Campbell, M.D.

HHV-8 Infection and Kaposi’s Sarcoma 

UCD

2/15/2007

Peter Palese 

Influenza Virus Pandemics: Past and Future

Mount Sinai School of Medicine

2/22/2007

Ed Janoff, M.D.

Prevention of HIV-associated Bacterial Pneumonia 

UCD

3/8/2007

Gary Doern, M.D.

Methicillin Resistant Staphylococcus aureus – The Coming Storm

University of Iowa

4/5/2007

Shannon Kasperbauer, M.D.

Pulmonary Mycobacterium Avium Complex

UCD

4/12/2007

Timothy Jenkins, M.D.

Evaluation and Classification of Staphylococcus aureus Bacteremia

UCD

4/19/2007

John Quinn, M.D. 

Emerging Issues of Resistance in Gram-Negative Bacteria

Professor of Medicine, Rush University  

4/26/2007

Sondra Crosby, M.D.

Caring for Refugee/Immigrant Women with HIV

Boston University Medical Center

5/3/2007

Joseph Morroni, M.D.

Biofilms: not just a sticky mess

UCD

5/10/2007

David Beckham, M.D.

Treatment of Viral Encephalitis

UCD

5/17/2007

Judith Currier, M.D.

Atherosclerosis and Metabolic Complications of HIV Infection

Tim Gill Lecture

5/31/2007

Kristin Brousseau, D.O.

Cognitive Impairment in the Aging HIV+ Patient

UCD

8/16/2007

Eoin Coakley, MD



Senior Medical Director, Clinical Research, The Royal College of Surgeons, Dublin, Ireland



9/6/2007

William Burman, MD

New TB Medications

Denver Health, UC Denver

9/13/2007

Priscilla Hsue, MD

HIV and Cardiac Disease

HCSF

9/27/2007

Mark Schaefer, ParmD

Personalized Medicine: Are We There Yet?

GSK, Group Director HIV

10/4/2007

Derrick Fine, MD

HIV and Kidney Disease

Johns Hopkins University

10/18/2007

Trish Perl, MD

Infection Control

Johns Hopkins University

11/1/2007

Bruce Mc Collister, MD

Antibiotic Tolerance

UC Denver

11/8/2007

Amiee Zaas, MD

Treating Invasive Fungal Infections in The Immunocompromised Patient

Duke University

11/15/2007

Lionel Mandell, MD

The New ATS/IDSA Guidelines for the Management of Community-Acquired Pneumonia

McMaster University

12/6/2007

Daniel Perlman, MD

Future Directions for MRSA Infections/New Diagnostic Tools and New Antimicrobials

Greater Denver Infectious Disease Specialists


2006


Date

Speaker

Title

Affiliation

1/5/2006

Randall Reeves, M.D.

The Skinny on TB: Anorexia, Debility, Nutrition or Phenotypic Risk Factors? 

UCD/DHHA

1/12/2006

Stanley Louie, Ph.D.

Clinical Impact of Blockade Cellular Transporters in HIV Arena




2/2/2006

Marilyn Levi, M.D. 

BK polyomavirus and transplantation

UCD

2/16/2006

Ches Thompson, M.D.

Epidemiology and Clinical Burden of Human Papillomavirus (HPV)

UCD

2/23/2006

Mary Ann DeGroote

MapQuest, the enduring hunt for M. paratuberculosis in Crohn's

UCD

3/2/2006

Herbert DuPont, M.D.

New Developments in Travelers' Diarrhea 

University of Houston

3/9/2006

Scott Letendre, M.D

Management of Central Nervous System Complications of HIV Infection

HIV Neurobehavioral Research Center and Antiviral Research Center, UCSD 

3/30/2006

Peter A Leone, MD 

The North Carolina Acute HIV Program:  Screening and Tracing the Transmission of HIV 

UNC-Chapel Hill

4/6/2006

Lyle R. Petersen, M.D., M.P.H.

West Nile Virus in the Americas

Division of Vector-borne Infectious Diseases, Center for Disease Control and Prevention

4/13/2006

Robert Bonomo, M.D. 

Antimicrobial Resistance and the Management of Serious Infections

Case Western Reserve School of Medicine

4/20/2006

Richard Martin, Ph.D

Asthma is an infectious disease.” 

National Jewish Medical and Research Center

4/27/2006

Milene Saavedra, M.D.

Management of Patients with CF

UCD

5/4/2006

Wafaa El-Sadr, M.D., MPH

The MTCT-Plus Program: Lessons Learned and Practical Aspects of Antiretroviral Therapy in Resource-Poor Settings

Harlem Hospital and Columbia U

5/11/2006

Ellie Schoenbaum, MD

Menopause and Beyond: HIV in Older Women

Montefiore Medical Center/Albert Einstein College of Medicine

5/18/2006

Lisa Young, M.D.




UCD

6/1/2006

Amie Meditz, M.D.

Projects Exploring Why Women Have Lower HIV-1 Viral Loads Early in Disease

UCD

6/8/2006

David Beckham, M.D.

Mechanisms of Disease in Viral Encephalitis

UCD

6/22/2006

Myron Levin, M.D.

Herpes Zoster: Pathogenesis and Prevention 

UCD

9/7/2006

Connie Price, M.D.

The Dying Prosthesis…and other Dilemmas in Orthopedic Device-Related Infections

UCD/DHHA

9/14/2006

Whitney High, M.D.

Tropical Medicine and Cutaneous Disease in the Returning Traveler

UCD

9/21/2006

Kieran Marr, M.D.

Fungal Infections in Immunocompromised Adults

University of Washington

10/5/2006

Mark Abzug, M.D.

The Enteroviruses: An Emerging Infectious Disease 

UCD

10/19/2006

Peter Chin-Hong, M.D.

HPV in MSM

UCSF

10/26/2006

Michelle Roland, M.D.

Post-exposure Prophylaxis

UCSF

11/2/2006

Jeff Lennox, M.D.

Research Strategies to care for the Impossibly Difficult Patient

Emory University

11/16/2006

Andy Zolopa, M.D. 

HIV Resistance and Clinical Implications 

Stanford University

12/7/2006

Dale Gerding, M.D.

C. difficile

Loyola University

2005


Date

Speaker

Title

Affiliation

1/6/2005

Kathyrn Holmes, Ph.D.

SARS Update 2005

UCD

1/20/2005

Michael Wong, M.D.

Update in SOT in HIV+ Recipients  

ID Beth Israel Deaconess/Harvard

1/27/2005

Sarah Parker, M.D.

Vaccines and autism: understanding the controversy 

UCD

2/3/2005

Alicia Cronquist

Foodborne Disease Epidemiology

CDPHE

2/10/2005

Cara Wilson, M.D.

Update of the EP-1090 HIV-1 DNA Therapeutic Vaccine Trial

UCD

2/17/2005

Monica Carten, M.D.

HIV Post-Exposure Prophylaxis for nonoccupational exposures 

UCD

3/3/2005

Susan Swindells, M.D.

Metabolic Complications of HIV Disease and Its Therapies

University of Nebraska

3/10/2005

Princy Kumar, M.D.

HIV as a Chronic Disease

Georgetown University

3/17/2005

Leland Shapiro, M.D.

Anthrax! Bacterial Pathogenesis and Novel Approach to Treatment

UCD

3/31/2005

Megan Clancy, M.D.

Clostridium difficile…Fact and Fiction

UCD

4/14/2005

Alison Elliott, M.D.

The impact of helminth infection in pregnancy on the response to immunisation and on disease incidence in infancy: preliminary results from a continuing intervention trial.

London School of Hygiene and Tropical Medicine 

4/21/2005

Bob Belknap, M.D.

the Law & Order of TB Control in 2005

UCD

5/5/2005

Kathryn Robertson, M.D.

"Dendritic Cell Phenotype and Function in HIV-1-infected Patients"

UCD

5/12/2005

Ruth Berggren, MD

Sealing it up and rolling it out: HIV care in resource poor countries.”

Tulane University

5/19/2005

Mark Abzug, M.D.

Pneumococcal Vaccination and Immune Reconstitution in HIV-Infected Children

UCD

5/26/2005

Ed Gardner, M.D.

"Is Risk-Based HIV Testing Effective?  New Data from Denver Health"

UCD

6/2/2005

Pam Skinner, PhD

In situ analysis of HIV and SIV specific CD8+ T cells

University of Minnesota

6/9/2005

Mark Cotton, M.B.

HIV in children from the Western Cape, South Africa – from bad to worse to better

Stellenbosch University

6/16/2005

William Burman, M.D.

"You can't always get what you want, but if you try sometimes... - a clinician's view of salvage antiretroviral therapy"

UCD

6/23/2005

Amie Meditz, M.D.

Sex Differences in Plasma HIV-1 Concentrations: A pilot study to investigate HIV-1 Replication and CCR5 Expression in Lymphoid Tissue of Women compared to Men

UCD

9/2/2005

Gary Dubin, M.D.

HPV Vaccine

GSK

9/8/2005

Kees Rietmeijer, M.D.

Lymphogranuloma venerum among Men Who Have Sex With Men

Denver Public Health

9/22/2005

Maggie Wierman, M.D.

Metabolic Bone Disease in HIV patients

UCD/Denver VAMC

9/29/2005

Adriana Weinberg, M.D.

Cytomegalovirus Infection in the Era of HAART: Better Immunity and Fewer Reactivations

UCD

10/20/2005

Stanley Derezinski, M.D.

Minimizing Antibiotic Resistance:  The Fluoroquinolones.

Stanford

10/27/2005

Peter Pappas, M.D.

Immunotherapy for Invasive Fungal Infections: Is There a Role in Clinical Care?

Univ of AL

11/3/2005

Mary Bessesen, M.D.

Nosocomial Aspergillosis

UCD

11/17/2005

Greg Everson, M.D.

Antiviral Therapy of Advanced Hepatitis C:  Pros and Cons

UCD


2004


Date

Speaker

Title

Affiliation

1/8/2004

Philip Keiser, M.D.

Utility of Cohort Comparisons of Anti-retroviral Regimens

UT Southwestern

1/15/2004

Jack Stapleton, M.D.

GB Virus:  A Major Factor in HIV Long Term Nonprogression

Univ of Iowa

1/29/2004

Kevin High, M.D. 

Infection and Immunity in Older Adults

Wake Forest University

2/5/2004

 Norbert Voelkel

Expression of HHV-8 in Primary Pulmonary Hypertension

UCD

2/19/2004

Kathryn Lee, M.D.

Resistant CMV in BMT Recipients 

UCD

3/4/2004

Marin Kollef, M.D.

Optimization of the antibiotic therapy for hospital-asasociated pneumonia

Washington University

3/18/2004

Megan Clancy, M.D.

Community and Hospital Acquired MRSA Infections at Denver Health

UCD

4/1/2004

Henry F. Chambers, M.D.

Community MRSA

UCSF

4/8/2004

Todd Kingdom, M.D.

Current Concepts on the Pathophysiology of Chronic Rhinosinusitis

UCD

4/15/2004

Ken Thomson, Ph.D.

Academic Perspectives in Emerging Issues of Resistance in Gram-Negative Bacteria

University of Nebraska

4/22/2004

Susan Cu Uvin, MD 

Gynecological Care: Concerns of HIV-Infected Women 

Brown University  

4/29/2004

Bill Burman, M.D.

Invasive nocardiosis - Can we ever move beyond anecdotes in the treatment of unusual, but severe infectious diseases?

UCD

5/20/2004

David Wyles, M.D.

HCV/HIV Co-infection Update and Beyond: In Vitro Activity and resistance to a HCV Serine Protease Inhibitor 

UCD

5/27/2004

Andrew Pavia, M.D.

Women, pregnancy and HIV: What have we learned in the last 10 years.

University of Utah

6/3/2004

John Koeppe, M.D.

HIV-1 specific T cell Responses in Viral Evolution – A Major Cause of Disease Progression?

UCD

6/10/2004

Ed Gardner, M.D.

Adherence to Antiretrovirals in the Denver Health System

UCD

6/17/2004

Bruce Walker, M.D. 




Harvard University

6/24/2004

Robert Belknap, M.D.

Tuberculosis Elimination: the Colorado Perspective

UCD

9/9/2004

Michael Miller, Ph.D.

Resistance, Replication Capacity and Intracellular Pharmacology of NRTIs

Gilead

9/16/2004

Arturo Casadeval, M.D., Ph.D

'New insights into cryptococcal pathogenesis and development of antibody therapy'

Albert Einstein College of Medicine

9/23/2004

J.J. Hakim, M.D.

Impact of HIV Epidemic on Clinical Practice in Zimbabwe

Tim McGill Annual Lecture

10/7/2004

Connie Price, M.D.

Science and Superstitions in Infection Control

UCD

10/14/2004

Jo-Anne van Burik, M.D.

Antifungal prophylaxis: Clinical updates

Univ of Minnesota

10/21/2004

Elizabeth Connick, M.D.

Why Have Efforts To Augment HIV-Specific Immunity Failed to Result in Virologic Control?  New Insights From Lymphoid Tissue Studies

UCD

10/28/2004

Michelle Barron, M.D.

Influenza in the 21st Century

UCD

11/4/2004

Michael Saubolle, Ph.D.

Interesting Case Presentations from the Southwest Deserts

University of Arizona

11/11/2004

Mike Pfaller, M.D.

Has Antifungal Testing Come of Age?

University of Iowa

11/18/2004

John Perfect, M.D.

Advancing the Art of Antifungal Therapy: New Therapeutic Options and Strategies

Duke University

12/2/2004

Chris Petropoulos, Ph.D.

A Closer Look at HIV-1 Co-Receptor Tropism in the Emerging Era of Entry Inhibitors 

Virologic Labs

12/9/2004

Alan T. Evangelista, Ph.D.

Antimicrobial Resistance Trends and Appropriate use of Antibiotics 

Ortho-McNeil Pharmaceuticals


2003


Date

Speaker

Title

Affiliation

1/9/2003

Thomas Patterson

New Antifungal Agents: New Choices

UTHSC-SA

1/16/2003

Dennis Maki

The Need for a New Paradigm for Control of Nosocomial Infection in the ICU

Univ of Wisconsin

1/23/2003

Frank Judson

Bioterrorism: A Holistic Approach to Assessing Risk and Planning for Control

UCD

1/30/2003

Steven Johnson

West Nile Virus

UCD

2/6/2003

Ed Abraham

New Treatments for Sepsis

UCD

2/20/2003

Judith Andersen

History of the Plague 

UCD

2/27/2003

Nalini Rao

An Update on the Diagnosis and Management of Osteomyelitis

University of Pittsburgh  

3/6/2003

Donna Sweet

HIV care: A Perspective on Women

University of Kansas

3/13/2003

Dan Kuritzkes

HIV Drug Resistance: Strategic Implications for Therapy

Harvard University

4/3/2003

Veronica Miller

Definition of Treatment Failure

George Washington University

4/10/2003

Ferric Fang

Can We Treat Infectious Diseases by Modulating Host Defenses?

University of Washington

4/17/2003

Joseph Falkinham

Epidemiology and Ecology of Mycobacterium avium 

Virginia Polytechnic University

4/24/2003

Kathleen Squires

Clinical Care Update: Antiretroviral Therapies for Women

USC

5/1/2003

John Koeppe

Mechanism of CD4+ T cell escape

UCD

5/8/2003

Bill Burman

Why isn't TB going away in Denver? Insights from conventional and molecular epidemiology

UCD

5/15/2003

James Neid

KSHV infection of pulmonary endothelial cells:  clinical and laboratory significance

UCD

5/22/2003

Mary Hamel

The Effect of Daily Cotrimoxazole for the Prevention of HIV-Related  Opportunistic Infections on the Development of Resistance in Common Pathogens in Africa

CDC

5/29/2003

David Wyles

“Toward an in vitro system to characterize novel anti-HCV compounds

UCD

6/5/2003

Mark Thrun

HIV Prevention: Moving Beyond Condoms

UCD

6/12/2003

Bruce McCollister

Interferon-gamma in host defense against S. typhimurium

UCD

6/19/2003

Kathryn Lee

CMV-Specific Immune Reconstitution in BMT Patients

UCD

6/26/2003

Charles Dinarello

"Specific anti-cytokine therapies work but at the expense of decreased host defense against infection."  

UCD

9/4/2003

Richard Ogden, Ph.D.

HIV Resistance, Fitness, and Pathogenicity:  Current Data and Ongoing Research

Agouron

9/11/2003

Mike Iseman, M.D.

Primum Non Nocere and RIF-PZA Treatment of Latent TB:  Mutually Exclusive?"

UCD

9/25/2003

Mark Sulkowski, M.D.

HCV in the HIV-infected Patient

Johns Hopkins

10/2/2003

Mahmoud A. Ghannoum, M.Sc., Ph.D.

Candida Biofilms and the Role of Antifungals

Case Western 

10/16/2003

David Simpson, M.D.

Neurological Complications of HIV

Mt. Sinai

10/23/2003

S. Ferrando, M.D.

Case Studies in HIV

Cornell University

10/30/2003

Dimitrios Kontiannis, M.D.

Evolving Epidemiology of Fungal Infections with a Special Focus on Candidemia

MD Anderson

11/6/2003

Ken Lichtenstein, M.D.

Antiretroviral Toxicities, An Alternative View

Rose Medical Center

11/13/2003

Max Salfinger, M.D.

HIV/TB Co-Infection Up-Date

NY State Dept of Health

11/20/2003

Nelson Gantz, M.D.

Chronic Fatigue Syndrome: Real or Imaginary

UCD/Boulder

12/4/2003

Ken Tyler, M.D.

West Nile Virus

UCD

12/11/2003

Marty St. Clair

Nucleoside Therapy in 2003; What Have We Learned and Where do we go From Here?

GSK


Download 277.87 Kb.

Share with your friends:




The database is protected by copyright ©ininet.org 2020
send message

    Main page